Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: Effects of reserpine

Journal of Neurochemistry

Volumn 100, Issue 3, 2007, Pages 810-821

  Verheij, M M M ^a   Cools, A R ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Dopamine pools; Individual differences; Microdialysis; Nucleus accumbens; Rats

Indexed keywords

DOPAMINE; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG SENSITIVITY; EXTRACELLULAR SPACE; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PH; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE;

ACIDOSIS; ADRENERGIC UPTAKE INHIBITORS; ALPHA-METHYLTYROSINE; ANIMALS; BEHAVIOR, ANIMAL; CYTOPLASMIC VESICLES; DOPAMINE; ENZYME INHIBITORS; EXPLORATORY BEHAVIOR; EXTRACELLULAR FLUID; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PRESYNAPTIC TERMINALS; PROTONS; RATS; RATS, WISTAR; RESERPINE; REWARD; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

RATTUS;

EID: 33846188869     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04259.x     Document Type: Article

References (94)

1. 2 with changes in ventilation. Neurosurgery 34, 466-470.
2. Arbuthnott G. W., Fairbrother I. S. and Butcher S. P. (1990) Dopamine release and metabolism in the rat striatum: an analysis by 'in vivo' brain microdialysis. Pharmacol. Ther. 48, 281-293.
3. Auclair A., Cotecchia S., Glowinski J. and Tassin J. P. (2002) D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. J. Neurosci. 22, 9150-9154.
4. Auclair A., Drouin C., Cotecchia S., Glowinski J. and Tassin J. P. (2004) 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur. J. Neurosci. 20, 3073-3084.
5. Bevins R. A., Klebaur J. E. and Bardo M. T. (1997) Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats. Behav. Pharmacol. 8, 113-123.
6. Braestrup C. (1977) Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats. J. Pharm. Pharmacol. 29, 463-470.
7. Butcher S. P., Fairbrother I. S., Kelly J. S. and Arbuthnott G. W. (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J. Neurochem. 50, 346-355.
8. Butcher S. P., Liptrot J. and Aburthnott G. W. (1991) Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci. Lett. 122, 245-248.
9. Cannizzaro C., Monastero R., Vacca M. and Martire M. (2003) [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions. Neurochem. Int. 43, 9-17.
10. Cappellen A. M., Rijpkema M., Heerschap A., Oeseburg B., Nijhuis J. G. and Jongsma H. W. (2003) Cerebral (31) P magnetic resonance spectroscopy and systemic acid-base balance during hypoxia in fetal sheep. Pediatr. Res. 54, 747-752.
11. Carboni E., Acquas E., Frau R. and Di Chiara G. (1989) Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur. J. Pharmacol. 164, 515-519.
12. Chefer V. I., Zakharova I. and Shippenberg T. S. (2003) Enhanced responsiveness to novelty and cocaine is associated with decreased basal dopamine uptake and release in the nucleus accumbens: quantitative microdialysis in rats under transient conditions. J. Neurosci. 23, 3076-3084.
13. Chiueh C. C. and Moore K. E. (1975) Blockade by reserpine of methylphenidate-induced release of brain dopamine. J. Pharmacol. Exp. Ther. 193, 559-563.
14. Colliver T. L., Pyott S. J., Achalabun M. and Ewing A. G. (2000) VMAT-mediated changes in quantal size and vesicular volume. J Neurosci. 20, 5276-5282.
15. Cools A. R. and Gingras M. A. (1998) Nijmegen high and low responders to novelty: a new tool in the search after the neurobiology of drug abuse liability. Pharmacol. Biochem. Behav. 60, 151-159.
16. Cools A. R. and Tuinstra T. (2003) Neurochemical evidence that mesolimbic noradrenaline directs mesolimbic dopamine, implying that noradrenaline, like dopamine, plays a key role in goal-directed and motivational behavior, in The Basal Ganglia VI (Advances in Behavioral Biology (Graybiel, A. M., Delong, M. R. and Kitai, S. T., eds), Vol. 54, pp. 323-334. Plenum Publishers, New York.
17. Cools A. R., Brachten R., Heeren D., Willemen A. and Ellenbroek B. (1990) Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res. Bull. 24, 49-69.
18. Cools A. R., Ellenbroek B. A., Gingras M. A., Engbersen A. and Heeren D. (1997) Differences in vulnerability and susceptibility to dexamphetamine in Nijmegen high and low responders to novelty: a dose-effect analysis of spatio-temporal programming of behaviour. Psychopharmacology (Berl) 132, 181-187.
19. Corrodi H. and Hanson L. C. (1966) Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia 10, 116-125.
20. Dahlstrom A., Fuxe K. and Hillarp N. A. (1965) The site of action of reserpine. Acta Pharmacol. Toxicol. (Copenh) 22, 277-292.
21. Davis M. (1985) Cocaine: excitatory effects on sensorimotor reactivity measured with acoustic startle. Psychopharmacology (Berl) 86, 31-36.
22. De Leonibus E., Verheij M. M., Mele A. and Cools A. (2006) Distinct kinds of novelty processing differentially increase extracellular dopamine in different brain regions. Eur. J. Neurosci. 23, 1332-1340.
23. Dellu F., Piazza P. V., Mayo W., Le Moal M. and Simon H. (1996) Novelty-seeking in rats - biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 34, 136-145.
24. DiLullo S. L. and Martin-Iverson M. T. (1992) Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion. Brain Res. 578, 161-167.
25. Drapeau P. and Nachshen D. A. (1988) Effects of lowering extracellular and cytosolic pH on calcium fluxes, cytosolic calcium levels, and transmitter release in presynaptic nerve terminals isolated from rat brain. J. Gen. Physiol. 91, 305-315.
26. Einhorn L. C., Johansen P. A. and White F. J. (1988) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 8, 100-112.
27. Eldridge F. L., Kiley J. P. and Millhorn D. E. (1984) Respiratory effects of carbon dioxide-induced changes of medullary extracellular fluid pH in cats. J. Physiol. 355, 177-189.
28. Eleff S. M., Sugimoto H., Shaffner D. H., Traystman R. J. and Koehler R. C. (1995) Acidemia and brain pH during prolonged cardiopulmonary resuscitation in dogs. Stroke 26, 1028-1034.
29. Elia J., Borcherding B. G., Rapoport J. L. and Keysor C. S. (1991) Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res. 36, 141-155.
30. van der Elst M. C., Verheij M. M., Roubos E. W., Ellenbroek B. A., Veening J. G. and Cools A. R. (2005) A single exposure to novelty differentially affects the accumbal dopaminergic system of apomorphine-susceptible and apomorphine-unsusceptible rats. Life Sci. 76, 1391-1406.
31. Finn I. B., Iuvone P. M. and Holtzman S. G. (1990) Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate. Neuropharmacology 29, 625-631.
32. Florin S. M., Kuczenski R. and Segal D. S. (1995) Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations. J. Pharmacol. Exp. Ther. 274, 231-241.
33. Fujiwara N., Warashina A. and Shimoji K. (1994) Characterization of low pH-induced catecholamine secretion in the rat adrenal medulla. J. Neurochem. 62, 1809-1815.
34. Gingras M. A. and Cools A. R. (1997) No major differences in locomotor responses to dexamphetamine in high and low responders to novelty: a study in Wistar rats. Pharmacol. Biochem. Behav. 57, 857-862.
35. Giorgi O., Corda M. G., Carboni G., Frau V., Valentini V. and Di Chiara G. (1997) Effects of cocaine and morphine in rats from two psychogenetically selected lines: a behavioral and brain dialysis study. Behav. Genet. 27, 537-546.
36. Gong L. W., Hafez I., Alvarez de-Toledo G. and Lindau M. (2003) Secretory vesicles membrane area is regulated in tandem with quantal size in chromaffin cells. J. Neurosci. 23, 7917-7921.
37. Greenhill L. L., Abikoff H. B., Arnold L. E., et al. (1996) Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J. Am. Acad. Child Adolesc. Psychiatry 35, 1304-1313.
38. Guan X. M. and McBride W. J. (1988) Amphetamine-induced in vivo release of dopamine in the striatum is influenced by local pH. Life Sci. 42, 2625-2631.
39. Heeringa M. J. and Abercrombie E. D. (1995) Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. J. Neurochem. 65, 192-200.
40. Henry J. P., Botton D., Sagne C., Isambert M. F., Desnos C., Blanchard V., Raisman-Vozari R., Krejci E., Massoulie J. and Gasnier B. (1994) Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J. Exp. Biol. 196, 251-262.
41. Hiroi N. and White N. M. (1990) The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm. Brain Res. 510, 33-42.
42. Hodges M. R., Klum L., Leekley T., Brozoski D. T., Bastasic J., Davis S., Wenninger J. M., Feroah T. R., Pan L. G. and Forster H. V. (2004) Effects on breathing in awake and sleeping goats of focal acidosis in the medullary raphe. J. Appl. Physiol. 96, 1815-1824.
43. Hooks M. S., Jones G. H., Smith A. D., Neill D. B. and Justice J.-B. J. (1991) Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse 9, 121-128.
44. Hooks M. S., Colvin A. C., Juncos J. L. and Justice J.-B. J. (1992) Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res. 587, 306-312.
45. Hooks M. S., Jones D. N., Holtzman S. G., Juncos J. L., Kalivas P. W. and Justice J.-B. J. (1994) Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology (Berl) 116, 217-225.
46. Hurd Y. L. and Ungerstedt U. (1989) Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 3, 48-54.
47. Imperato A. and Di Chiara G. (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci. 4, 966-977.
48. Jiang L. H., Ashby C.-R. J., Kasser R. J. and Wang R. Y. (1990) The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res. 513, 156-160.
49. Johnson R.-G. J. (1987) Proton pumps and chemiosmotic coupling as a generalized mechanism for neurotransmitter and hormone transport. Ann. N Y Acad. Sci. 493, 162-177.
50. Justice J.-B. J., Nicolaysen L. C. and Michael A. C. (1988) Modeling the dopaminergic nerve terminal. J. Neurosci. Methods 22, 239-252.
51. Kabbaj M. (2004) Neurobiological bases of individual differences in emotional and stress responsiveness: high responders-low responders model. Arch. Neurol. 61, 1009-1012.
52. van der Kam E. L., Ellenbroek B. A. and Cools A. R. (2005) Gene-environment interactions determine the individual variability in cocaine self-administration. Neuropharmacology 48, 685-695.
53. Kannari K., Tanaka H., Maeda T., Tomiyama M., Suda T. and Matsunaga M. (2000) Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation. J. Neurochem. 74, 263-269.
54. Lee T. H., Balu R., Davidson C. and Ellinwood E. H. (2001) Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. Synapse 41, 301-310.
55. Leviel V., Gobert A. and Guibert B. (1989) Direct observation of dopamine compartmentation in striatal nerve terminal by 'in vivo' measurement of the specific activity of released dopamine. Brain Res. 499, 205-213.
56. Mantsch J. R., Ho A., Schlussman S. D. and Kreek M. J. (2001) Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology (Berl) 157, 31-39.
57. McMillen B. A. (1983) CNS Stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol. Sci. 4, 429-432.
58. McMillen B. A., German D. C. and Shore P. A. (1980) Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochem. Pharmacol. 29, 3045-3050.
59. Mylecharane E. J. (1996) Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies. Behav. Brain Res. 73, 1-5.
60. Nachshen D. A. and Drapeau P. (1988) The regulation of cytosolic pH in isolated presynaptic nerve terminals from rat brain. J. Gen. Physiol. 91, 289-303.
61. Pan J. T., Hooth M. J., Lookingland K. J., Moore K. E. and Marks T. A. (1993) Comparison of the effects of losulazine and reserpine on central aminergic neurons. Toxicol. Appl. Pharmacol. 123, 26-33.
62. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Elsevier, Academic Press, San Diego.
63. Pei Q., Zetterstrom T., Leslie R. A. and Grahame-Smith D. G. (1993) 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. Eur. J. Pharmacol. 230, 63-68.
64. Piazza P. V., Deminiere J. M., Le Moal M. and Simon H. (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245, 1511-1513.
65. Piazza P. V., Rouge-Pont F., Deminiere J. M., Kharoubi M., Le Moal M. and Simon H. (1991) Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res. 567, 169-174.
66. Piazza P. V., Deroche-Gamonent V., Rouge-Pont F. and Le Moal M. (2000) Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J. Neurosci. 20, 4226-4232.
67. Pifl C., Drobny H., Reither H., Hornykiewicz O. and Singer E. A. (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47, 368-373.
68. Pothos E. N., Davila V. and Sulzer D. (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J. Neurosci. 18, 4106-4118.
69. Ranaldi R., Bauco P., McCormick S., Cools A. R. and Wise R. A. (2001) Equal sensitivity to cocaine reward in addiction-prone and addiction-resistant rat genotypes. Behav. Pharmacol. 12, 527-534.
70. Rentero N., Bruandet N., Milne B. and Quintin L. (1998) Catechol activation in rat rostral ventrolateral medulla after systemic isocapnic metabolic acidosis. Am. J. Physiol. 275, R350-R356.
71. Rouge-Pont F., Piazza P. V., Kharouby M., Le Moal M. and Simon H. (1993) Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study. Brain Res. 602, 169-174.
72. Sabol K. E. and Seiden L. S. (1998) Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis. Brain Res. 806, 69-78.
73. Saigusa T., Tuinstra T., Koshikawa N. and Cools A. R. (1999) High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behaviour and release of accumbal dopamine. Neuroscience 88, 1153-1163.
74. Scheel-Kruger J. (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur. J. Pharmacol. 14, 47-59.
75. Scheel-Kruger J., Braestrup C., Nielson M., Golembiowska K. and Mogilnicka E. (1977) Cocaine: discussion on the role of dopamine in the biochemical mechanism of action, in Advances in Behavioral Biology (Ellinwood E. H. Jr and Kilbey M. M., eds), pp. 373-407. Plenum Press, New York.
76. Schoemaker H. and Nickolson V. J. (1983) Dopamine uptake by rat striatal synaptosomes: a compartmental analysis. J. Neurochem. 41, 684-690.
77. Shapiro J. I., Whalen M., Kucera R., Kindig N., Filley G. and Chan L. (1989) Brain pH responses to sodium bicarbonate and Carbicarb during systemic acidosis. Am. J. Physiol. 256, H1316-H1321.
78. Somjen G. G., Allen B. W., Balestrino M. and Aitken P. G. (1987) Pathophysiology of pH and Ca2+ in bloodstream and brain. Can. J. Physiol. Pharmacol. 65, 1078-1085.
79. Spencer T. J., Wilens T. E., Biederman J., Weisler R. H., Read S. C. and Pratt R. (2006) Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin.. Ther 28, 266-279.
80. Stahle L. and Ungerstedt U. (1990) Yawning and suppression of exploration induced by dopamine agonists: no relation to extracellular striatal levels of dopamine. Pharmacol. Biochem. Behav. 35, 201-209.
81. Sulzer D., Chen T. K., Lau Y. Y., Kristensen H., Rayport S. and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102-4108.
82. Tomiyama K., Noguchi M., Koshikawa N. and Kobayashi M. (1993) YM-09151-2 but not 1-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism. J. Neurochem. 60, 1690-1695.
83. Tuinstra T. and Cools A. R. (2000a) High and low responders to novelty: effects of adrenergic agents on the regulation of accumbal dopamine under challenged and non-challenged conditions. Neuroscience 99, 55-64.
84. Tuinstra T. and Cools A. R. (2000b) Newly synthesized dopamine in the nucleus accumbens is regulated by beta-adrenergic, but not alpha-adrenergic, receptors. Neuroscience 98, 743-747.
85. Venton B. J., Seipel A. T., Phillips P. E., Wetsel W. C., Gitler D., Greengard P., Augustine G. J. and Wightman R. M. (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J. Neurosci. 26, 3206-3209.
86. Volkow N. D. and Swanson J. M. (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 160, 1909-1918.
87. Volkow N. D., Wang G. J., Fowler J. S., et al. (2002) Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43, 181-187.
88. Wagner J. A. (1985) Structure of catecholamine secretory vesicles from PC12 cells. J. Neurochem. 45, 1244-1253.
89. Watanabe S., Aono Y., Fusa K., Takada K., Saigusa T., Koshikawa N. and Cools A. R. (2005) Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine. Neuroscience 136, 251-257.
90. Wilens T. E. (2003) Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs 63, 2395-2411.
91. Winkler H., Apps D. K. and Fischer-Colbrie R. (1986) The molecular function of adrenal chromaffin granules: established facts and unresolved topics. Neuroscience 18, 261-290.
92. Wooters T. E., Dwoskin L. P. and Bardo M. T. (2006) Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) 188, 18-27.
93. Yan Q. S. (2003) Involvement of non-exocytotic mechanisms in ethanol-induced in vivo dopamine release: comparisons with cocaine. Eur. J. Pharmacol. 477, 37-44.
94. Yoshitake T., Yoshitake S., Fujino K., Nohta H., Yamaguchi M. and Kehr J. (2004) High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex. J. Neurosci. Methods 140, 163-168.